Information  X 
Enter a valid email address

Nuformix PLC Ord 0.1P (NFX)

Date Time Source Announcement
13 Feb 2020 4:35 pm
RNS
Price Monitoring Extension
12 Feb 2020 4:10 pm
RNS
Notification of Major Holdings
05 Feb 2020 5:05 pm
RNS
Operational Update
  4:45 pm
RNS
Resignation of Dave Tapolczay
  2:24 pm
RNS
Director Dealing
  2:19 pm
RNS
Notification of Major Holdings
27 Jan 2020 7:00 am
RNS
Major Shareholding Notification
  7:00 am
RNS
Resignation of John Lidgey
15 Jan 2020 12:43 pm
RNS
Amendment to Notice
10 Jan 2020 11:45 am
RNS
Issue of Equity
08 Jan 2020 8:17 am
RNS
Holding(s) in Company
24 Dec 2019 7:00 am
RNS
Half-year Report
25 Nov 2019 4:41 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
  7:00 am
RNS
Update and Placing Announcement
28 Oct 2019 2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
  8:30 am
RNS
Issue of Equity
25 Oct 2019 11:11 am
RNS
Statement re. Share Price Movement
  9:05 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
20 Sep 2019 2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
10 Sep 2019 4:49 pm
RNS
AGM Results
  7:00 am
RNS
Directorate Change
09 Sep 2019 7:00 am
RNS
Ebers Cannabinoid Collaboration Update
06 Sep 2019 7:30 am
RNS
Appointment of Dr Muhunthan Thillai
04 Sep 2019 7:30 am
RNS
Holding(s) in Company
01 Aug 2019 9:30 am
RNS
Annual Financial Report
29 Jul 2019 7:00 am
RNS
Holding(s) in Company
18 Jul 2019 7:00 am
RNS
Final Results
07 Jun 2019 7:00 am
RNS
Holding(s) in Company
06 Jun 2019 7:00 am
RNS
Holding(s) in Company
30 May 2019 11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
  7:01 am
RNS
Positive Results for NXP001 Clinical Trial
28 May 2019 7:00 am
RNS
Holding(s) in Company - Amendment
24 May 2019 7:30 am
RNS
Holding(s) in Company
  7:00 am
RNS
Loan Conversion
22 May 2019 7:00 am
RNS
Holding(s) in Company
  7:00 am
RNS
Holding(s) in Company
  7:00 am
RNS
Holding(s) in Company
15 May 2019 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  7:00 am
RNS
Nuformix Achieves 2nd NXP001 Development Milestone
10 May 2019 9:00 am
RNS
Price Monitoring Extension
08 May 2019 7:30 am
RNS
Holding(s) in Company
09 Apr 2019 4:41 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  7:00 am
RNS
Strategic Cannabinoid Agreement
05 Apr 2019 7:00 am
RNS
Notification Major Share Interests
22 Mar 2019 7:00 am
RNS
Nuformix Commences NXP001 Clinical Trial
27 Feb 2019 7:00 am
RNS
MHRA approval for NXP001
20 Feb 2019 6:16 pm
RNS
Holding(s) in Company
20 Dec 2018 7:00 am
RNS
Unaudited Half Year Results
03 Dec 2018 7:00 am
RNS
Reports Results from Novel IPF Pre-Clinical Trial
27 Nov 2018 7:00 am
RNS
Expansion of NXP001 Agreement & Milestone Payment
28 Sep 2018 10:09 am
RNS
Director/PDMR Shareholding
  7:00 am
RNS
Additional New NXP002 Patent Filing
19 Sep 2018 2:33 pm
RNS
Result of AGM
 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t